Replimune Group, Inc. - REPL
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| May 20, 2026 | Chief Medical Officer | S | D | 14,023.0 | 5.08 | 71,236.84 | 235,662.0 | View | |
| May 20, 2026 | Chief Accounting Officer | S | D | 7,894.0 | 5.08 | 40,101.52 | 107,057.0 | View | |
| May 20, 2026 | Chief Commercial Officer | S | D | 8,626.0 | 5.08 | 43,820.08 | 192,962.0 | View | |
| May 20, 2026 | — | S | D | 17,657.0 | 5.08 | 89,697.56 | 1,412,414.0 | View | |
| May 20, 2026 | Chief Executive Officer | S | D | 37,324.0 | 5.08 | 189,605.92 | 747,492.0 | View | |
| May 20, 2026 | Chief Financial Officer | S | D | 7,812.0 | 5.08 | 39,684.96 | 236,556.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | Chief Commercial Officer | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Apr 07, 2026 | Chief Commercial Officer | A | A | 50,000.0 | 0.0 | 0.0 | 201,588.0 | View | |
| Apr 07, 2026 | — | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Apr 07, 2026 | — | A | A | 50,000.0 | 0.0 | 0.0 | 1,430,071.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | Chief Medical Officer | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Apr 07, 2026 | Chief Medical Officer | A | A | 50,000.0 | 0.0 | 0.0 | 249,685.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | Chief Accounting Officer | A | A | 55,000.0 | 0.0 | 0.0 | 55,000.0 | View | |
| Apr 07, 2026 | Chief Accounting Officer | A | D | 36,667.0 | 0.0 | 0.0 | 114,951.0 | View | |
| Apr 07, 2026 | Chief Executive Officer | A | A | 376,860.0 | 0.0 | 0.0 | 376,860.0 | View | |
| Apr 07, 2026 | Chief Executive Officer | A | A | 251,240.0 | 0.0 | 0.0 | 784,816.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 07, 2026 | Chief Financial Officer | A | A | 75,000.0 | 0.0 | 0.0 | 75,000.0 | View | |
| Apr 07, 2026 | Chief Financial Officer | A | A | 50,000.0 | 0.0 | 0.0 | 244,368.0 | View | |
| Apr 07, 2026 | — | A | A | 44,500.0 | 0.0 | 0.0 | 44,500.0 | View | |
| Apr 06, 2026 | Chief Commercial Officer | S | D | 6,500.0 | 8.01 | 52,065.0 | 151,588.0 | View | |
| Feb 20, 2026 | — | G | D | 25,000.0 | 0.0 | 0.0 | 1,380,071.0 | View | |
| Dec 19, 2025 | Chief Accounting Officer | A | A | 10,000.0 | 0.0 | 0.0 | 78,284.0 | View | |
| Dec 19, 2025 | Chief Executive Officer | A | A | 200,000.0 | 0.0 | 0.0 | 533,576.0 | View | |
| Dec 19, 2025 | Chief Financial Officer | A | A | 60,000.0 | 0.0 | 0.0 | 194,368.0 | View | |
| Dec 19, 2025 | Chief Commercial Officer | A | A | 35,000.0 | 0.0 | 0.0 | 158,088.0 | View | |
| Dec 19, 2025 | Chief Medical Officer | A | A | 60,000.0 | 0.0 | 0.0 | 199,685.0 | View | |
| Dec 11, 2025 | — | M | D | 3,169.0 | 0.0 | 0.0 | 0.0 | View | |
| Dec 11, 2025 | — | S | D | 3,169.0 | 10.4 | 32,957.6 | 0.0 | View | |
| Dec 11, 2025 | — | M | A | 3,169.0 | 1.75 | 5,545.75 | 3,169.0 | View | |
| Dec 04, 2025 | Chief Executive Officer | S | D | 10,000.0 | 11.13 | 111,300.0 | 333,576.0 | View |